Wealth management bristol

Its market cap is upwards of $118 billion, and in 2023 its top line was worth $45 billion, with net income of nearly $8 billion. There is, quite simply, no way that a business of that enormous size could grow fast enough to make anyone rich quick. As the pharmaceutical research and development (R&D) cycle takes seven years on average, there's a long delay between when Bristol-Myers conceives new programs and when -- or to be more accurate, if -- it commercializes them and realizes sales revenue. Money Marketing Events Be the first to hear about our industry-leading annual conferences and events, including the Money Marketing Awards and Money Marketing Interactive Leeds and London. Private equity-backed M&A in mid-cap UK healthcare is trending up, offering potential deal-linked upside for wealth management Bristol portfolios. The sector has grown market cap by 9% YTD, signalling institutional appetite.